REG - Kosmos Energy Ltd - Director/PDMR Shareholding
09/06/2025 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250609:nRSI8770La&default-theme=true
RNS Number : 8770L Kosmos Energy Limited 09 June 2025
Kosmos Energy Ltd (the "Company")
PDMR Shareholding
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE
EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES
9 June 2025
The following Persons Discharging Managerial Responsibilities ("PDMRs") have
had changes in their shareholdings of Common Shares in the Company:
PDMR Date of transaction No. of shares vested No. of shares granted No. of shares sold or withheld
Roy A. Franklin 4 June 2025 0 0 299
Roy A. Franklin 5 June 2025 0 96,591 0
Deanna L. Goodwin 5 June 2025 0 96,591 0
Sir John Douglas Kelso Grant 4 June 2025 0 0 275
Sir John Douglas Kelso Grant 5 June 2025 0 0 27,923
Sir John Douglas Kelso Grant 5 June 2025 0 96,591 0
Maria Moraeus Hanssen 5 June 2025 0 96,591 0
Adebayo O. Ogunlesi 5 June 2025 0 96,591 0
Steven M. Sterin 5 June 2025 0 96,591 0
J. Michael Stice 5 June 2025 0 96,591 0
The Notification of Dealing Form for each PDMR, which provides full details of
the transactions outlined above, can be found below.
This notification is made in accordance with Article 19 of the EU Market Abuse
Regulation.
Josh R. Marion
Senior Vice President, General Counsel and Corporate Secretary
CONTACT:
Investor Relations
Jamie Buckland
+44 203 954 2831
jbuckland@kosmosenergy.com
Media Relations
Thomas Golembeski
+1-214-445-9674
tgolembeski@kosmosenergy.com
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Roy A. Franklin
b) Position / status Director
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 299 shares withheld by the Issuer to satisfy the tax withholding requirement
arising from the vesting of restricted share units granted to the reporting
person under the Issuer's Long Term Incentive Plan (the "Plan").
Shares granted or vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 1.81
Volume 299
Total 541.19
Aggregated information
e)
Price 1.81
Volume 299
Total 541.19
f) Date of the transactions 4 June 2025
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 96,591 restricted share units granted to the reporting person on June 5, 2025
under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026
or the day immediately preceding the date of the Issuer's first annual
shareholder meeting following the date of grant, subject to the terms of the
Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c) Currency USD
Price 1.76
Volume 96,591
Total 170,000.16
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
Aggregated information
e)
Price 1.76
Volume 96,591
Total 170,000.16
f) Date of the transactions 5 June 2025
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Deanna L. Goodwin
b) Position / status Director
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 96,591 restricted share units granted to the reporting person on June 5, 2025
under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026
or the day immediately preceding the date of the Issuer's first annual
shareholder meeting following the date of grant, subject to the terms of the
Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c) Currency USD
Price 1.76
Volume 96,591
Total 170,000.16
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
Aggregated information
e)
Price 1.76
Volume 96,591
Total 170,000.16
f) Date of the transactions 5 June 2025
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Sir John Douglas Kelso Grant
b) Position / status Director
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 275 shares withheld by the Issuer to satisfy the tax withholding requirement
arising from the vesting of restricted share units granted to the reporting
person under the Issuer's Long Term Incentive Plan (the "Plan").
Shares granted or vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 1.81
Volume 275
Total 497.75
Aggregated information
e)
Price 1.81
Volume 275
Total 497.75
f) Date of the transactions 4 June 2025
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 27,923 shares sold to partially cover income tax liability from the vesting of
restricted share units granted to the reporting person under the Plan.
Shares granted or vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 1.81
Volume 27,923
Total 50,540.63
Aggregated information
e)
Price 1.81
Volume 27,923
Total 50,540.63
f) Date of the transactions 5 June 2025
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 96,591 restricted share units granted to the reporting person on June 5, 2025
under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026
or the day immediately preceding the date of the Issuer's first annual
shareholder meeting following the date of grant, subject to the terms of the
Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c) Currency USD
Price 1.76
Volume 96,591
Total 170,000.16
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
Aggregated information
e)
Price 1.76
Volume 96,591
Total 170,000.16
f) Date of the transactions 5 June 2025
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Maria Moraeus Hanssen
b) Position / status Director
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 96,591 restricted share units granted to the reporting person on June 5, 2025
under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026
or the day immediately preceding the date of the Issuer's first annual
shareholder meeting following the date of grant, subject to the terms of the
Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c) Currency USD
Price 1.76
Volume 96,591
Total 170,000.16
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
Aggregated information
e)
Price 1.76
Volume 96,591
Total 170,000.16
f) Date of the transactions 5 June 2025
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Adebayo O. Ogunlesi
b) Position / status Director
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 96,591 restricted share units granted to the reporting person on June 5, 2025
under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026
or the day immediately preceding the date of the Issuer's first annual
shareholder meeting following the date of grant, subject to the terms of the
Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c) Currency USD
Price 1.76
Volume 96,591
Total 170,000.16
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
e) Aggregated information
Price 1.76
Volume 96,591
Total 170,000.16
f) Date of the transactions 5 June 2025
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Steven M. Sterin
b) Position / status Director
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 96,591 restricted share units granted to the reporting person on June 5, 2025
under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026
or the day immediately preceding the date of the Issuer's first annual
shareholder meeting following the date of grant, subject to the terms of the
Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c) Currency USD
Price 1.76
Volume 96,591
Total 170,000.16
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
e) Aggregated information
Price 1.76
Volume 96,591
Total 170,000.16
f) Date of the transactions 5 June 2025
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name J. Michael Stice
b) Position / status Director
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 96,591 restricted share units granted to the reporting person on June 5, 2025
under the Plan and are scheduled to vest 100% on the earlier of June 5, 2026
or the day immediately preceding the date of the Issuer's first annual
shareholder meeting following the date of grant, subject to the terms of the
Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c) Currency USD
Price 1.76
Volume 96,591
Total 170,000.16
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
e) Aggregated information
Price 1.76
Volume 96,591
Total 170,000.16
f) Date of the transactions 5 June 2025
g) Place of the transaction NYSE
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHSSUFIMEISEEMRecent news on Kosmos Energy
See all newsREG - Kosmos Energy Ltd - Report on Payments to Govts
AnnouncementREG - Kosmos Energy Ltd - Director/PDMR Shareholding
AnnouncementREG - Kosmos Energy Ltd - Results of Annual Stockholders Meeting
AnnouncementREG - Kosmos Energy Ltd - Ghana license extensions
AnnouncementREG - Kosmos Energy Ltd - 1st Quarter Results
Announcement